Trials / Completed
CompletedNCT02805348
Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney Disease
Long-Term Specified Drug Use-Results Survey in Patients With Pre-dialysis Chronic Kidney Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 144 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess the long-term safety and efficacy of bixalomer under post-marketed setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bixalomer | Oral |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2018-12-31
- Completion
- 2018-12-31
- First posted
- 2016-06-20
- Last updated
- 2024-10-16
Locations
14 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02805348. Inclusion in this directory is not an endorsement.